A.R.T. Advisors’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-22,500
Closed -$590K 1895
2017
Q2
$590K Sell
22,500
-5,400
-19% -$133K 0.03% 735
2017
Q1
$652K Buy
27,900
+10,100
+57% +$249K 0.03% 713
2016
Q4
$447K Buy
+17,800
New +$449K 0.03% 798
2016
Q3
Sell
-47,909
Closed -$1.18M 1479
2016
Q2
$1.18M Buy
47,909
+18,442
+63% +$458K 0.06% 484
2016
Q1
$651K Buy
29,467
+1,800
+7% +$47.9K 0.03% 760
2015
Q4
$968K Buy
27,667
+17,082
+161% +$535K 0.05% 579
2015
Q3
$301K Buy
+10,585
New +$356K 0.01% 1045
2014
Q3
Sell
-34,041
Closed -$973K 1670
2014
Q2
$973K Buy
+34,041
New +$947K 0.05% 518
2014
Q1
Sell
-31,312
Closed -$673K 1693
2013
Q4
$673K Buy
31,312
+16,492
+111% +$300K 0.04% 650
2013
Q3
$196K Sell
14,820
-19,492
-57% -$263K 0.01% 1143
2013
Q2
$475K Buy
+34,312
New +$486K 0.02% 896

Other funds holding PMC

A.R.T. Advisors's PMC Position: Q3 2017 in Review

A.R.T. Advisors sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 22,500 shares — an estimated $590K sold.

A.R.T. Advisors first reported a position in PMC in Q2 2013 and held it in 11 quarters. The position peaked at $1.18M in Q2 2016. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

  • A.R.T. Advisors reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 22,500 PharMerica Corporation shares in Q3 2017, an estimated $590K.
  • A.R.T. Advisors first reported a position in PharMerica Corporation in Q2 2013 and held it in 11 quarters.
  • A.R.T. Advisors's PharMerica Corporation position peaked at $1.18M in Q2 2016.
  • 150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on A.R.T. Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.